Detalhe da pesquisa
1.
Cladribine Effects on T and B Cells and T Cell Reactivity in Multiple Sclerosis.
Ann Neurol
; 94(3): 518-530, 2023 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37191113
2.
Prognostic factors for disease activity in newly diagnosed teriflunomide-treated patients with multiple sclerosis: a nationwide Danish study.
J Neurol Neurosurg Psychiatry
; 2024 Apr 03.
Artigo
Inglês
| MEDLINE | ID: mdl-38569873
3.
Risk of cardiovascular disease in patients with multiple sclerosis treated with fingolimod compared to natalizumab: A nationwide cohort study of 2095 patients in Denmark.
Mult Scler
; 30(2): 184-191, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-38205784
4.
Torben Fog - A Danish pioneer in a multi-faceted spectrum of multiple sclerosis research.
Mult Scler
; 30(6): 623-629, 2024 May.
Artigo
Inglês
| MEDLINE | ID: mdl-38523325
5.
Extended interval dosing with ocrelizumab in multiple sclerosis.
Mult Scler
; : 13524585241245296, 2024 Apr 22.
Artigo
Inglês
| MEDLINE | ID: mdl-38646949
6.
A wearable device perspective on the standard definitions of disability progression in multiple sclerosis.
Mult Scler
; 30(1): 103-112, 2024 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-38084497
7.
Citrullination of myelin basic protein induces a Th17-cell response in healthy individuals and enhances the presentation of MBP85-99 in patients with multiple sclerosis.
J Autoimmun
; 139: 103092, 2023 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37506490
8.
Pregnancy outcomes after early fetal exposure to injectable first-line treatments, dimethyl fumarate, or natalizumab in Danish women with multiple sclerosis.
Eur J Neurol
; 30(1): 162-171, 2023 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36098960
9.
Plasma neurofilament light significantly decreases following treatment in Lyme neuroborreliosis and is not associated with persistent symptoms.
Eur J Neurol
; 30(5): 1371-1377, 2023 05.
Artigo
Inglês
| MEDLINE | ID: mdl-36692938
10.
The peripheral endocannabinoid system and its association with biomarkers of inflammation in untreated patients with multiple sclerosis.
Eur J Neurol
; 30(10): 3212-3220, 2023 10.
Artigo
Inglês
| MEDLINE | ID: mdl-37337838
11.
Cluster headache polygenetic risk and known functional variants of CYP3A4 are not associated with treatment response.
Eur J Neurol
; 30(5): 1425-1434, 2023 05.
Artigo
Inglês
| MEDLINE | ID: mdl-36773010
12.
Linking lesions in sensorimotor cortex to contralateral hand function in multiple sclerosis: a 7â T MRI study.
Brain
; 145(10): 3522-3535, 2022 10 21.
Artigo
Inglês
| MEDLINE | ID: mdl-35653498
13.
Rebound of clinical disease activity after fingolimod discontinuation? A nationwide cohort study of patients in Denmark.
J Neurol Neurosurg Psychiatry
; 2022 Sep 28.
Artigo
Inglês
| MEDLINE | ID: mdl-36171103
14.
Time to first treatment and risk of disability pension in relapsing-remitting multiple sclerosis.
J Neurol Neurosurg Psychiatry
; 93(8): 858-864, 2022 08.
Artigo
Inglês
| MEDLINE | ID: mdl-35688630
15.
Extended dosing of monoclonal antibodies in multiple sclerosis.
Mult Scler
; 28(13): 2001-2009, 2022 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-34949134
16.
Pregnancy in women with MS: Impact on long-term disability accrual in a nationwide Danish Cohort.
Mult Scler
; 28(8): 1239-1247, 2022 07.
Artigo
Inglês
| MEDLINE | ID: mdl-34791952
17.
Peripheral helper T cells in the pathogenesis of multiple sclerosis.
Mult Scler
; 28(9): 1340-1350, 2022 08.
Artigo
Inglês
| MEDLINE | ID: mdl-35112578
18.
Charting a global research strategy for progressive MS-An international progressive MS Alliance proposal.
Mult Scler
; 28(1): 16-28, 2022 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34850641
19.
Ocrelizumab treatment in multiple sclerosis: A Danish population-based cohort study.
Eur J Neurol
; 29(2): 496-504, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-34644452
20.
Assessment of commonly used methods to determine myelin-reactivity of T cells in multiple sclerosis.
Clin Immunol
; 230: 108817, 2021 09.
Artigo
Inglês
| MEDLINE | ID: mdl-34352391